Почетна › Гојазност › Indijana › Indianapolis
Kliničke studije za Гојазност u gradu Indianapolis, IN
22 studija za Гојазност traži učesnike na lokacijama u gradu Indianapolis i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Тражи се учесникФаза 3
- DM Clinical Research - Indianapolis, Indianapolis
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Тражи се учесникФаза 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 14 ми удаљено
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Тражи се учесникФаза 3
- Riley Hospital for Children, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Тражи се учесникФаза 3
- DM Clinical Research - Indianapolis, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Тражи се учесникФаза 3
- Indiana University Health University Hospital, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Тражи се учесникФаза 3
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Тражи се учесникФаза 3
- Riley Hospital for Children, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Тражи се учесникФаза 2
- Investigators Research Group, Brownsburg · 14 ми удаљено
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Тражи се учесникФаза 2
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Тражи се учесникФаза 3
- Ascension Medical Group, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Тражи се учесник
- Indiana University, Indianapolis
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Тражи се учесникФаза 3
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Тражи се учесникФаза 3
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Тражи се учесникФаза 3
- Midwest Inst For Clin Res, Indianapolis
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Тражи се учесникФаза 3
- Midwest Inst For Clin Res, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Тражи се учесникФаза 3
- AURORA-2 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Тражи се учесникФаза 3
- AURORA-1 Clinical Site, Indianapolis
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Тражи се учесникФаза 3
- Midwest Inst For Clin Res, Indianapolis
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Тражи се учесникФаза 2
- Indiana University School of Medicine, Indianapolis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Тражи се учесникФаза 3
- Indiana University Health Methodist Hospital, Indianapolis
A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
Тражи се учесникЗдраве особе су добродошле
- Indiana University Hospital, Indianapolis
Fibrosis Lessens After Metabolic Surgery
Тражи се учесникФаза 4Здраве особе су добродошле
- Indiana University, Indianapolis
Studije za Гојазност u drugim gradovima
- Houston, TX44 студија
- Chicago, IL40 студија
- New York City, NY39 студија
- San Antonio, TX39 студија
- Washington, DC34 студија
- Dallas, TX33 студија
- Orlando, FL33 студија
- Miami, FL28 студија
- Boston, MA26 студија
- Atlanta, GA26 студија
- Los Angeles, CA25 студија
- St. Louis, MO25 студија
Ostale studije u gradu Indianapolis
- Немалоклетни карцином плућа32 студија
- Рак (све врсте)24 студија
- Затајење срца24 студија
- Рак дојке19 студија
- Рак јајника18 студија
- Метастатски карцином17 студија
- Колоректални карцином17 студија
- Кардиоваскуларне болести16 студија
- Рак плућа16 студија
- Dijabetes tipa 114 студија
- Гојазност14 студија
- Алцхајмерова болест14 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.